Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

221 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The course of negative symptoms in first-episode schizophrenia and its predictors: A prospective two-year follow-up study.
Mezquida G, Cabrera B, Bioque M, Amoretti S, Lobo A, González-Pinto A, Espliego A, Corripio I, Vieta E, Castro-Fornieles J, Bergé D, Escartí MJ, Ibañez Á, Penadés R, Sánchez-Torres AM, Bernardo M; PEPs Group. Mezquida G, et al. Among authors: cabrera b. Schizophr Res. 2017 Nov;189:84-90. doi: 10.1016/j.schres.2017.01.047. Epub 2017 Feb 6. Schizophr Res. 2017. PMID: 28185786
Assessing clinical and functional outcomes in a gene-environment interaction study in first episode of psychosis (PEPs).
Bernardo M, Bioque M, Parellada M, Saiz Ruiz J, Cuesta MJ, Llerena A, Sanjuán J, Castro-Fornieles J, Arango C, Cabrera B; PEPs Group. Bernardo M, et al. Among authors: cabrera b. Rev Psiquiatr Salud Ment. 2013 Jan-Mar;6(1):4-16. doi: 10.1016/j.rpsm.2012.11.001. Epub 2012 Dec 1. Rev Psiquiatr Salud Ment. 2013. PMID: 23206389 Clinical Trial. English, Spanish.
Identifying gene-environment interactions in schizophrenia: contemporary challenges for integrated, large-scale investigations.
European Network of National Networks studying Gene-Environment Interactions in Schizophrenia (EU-GEI); van Os J, Rutten BP, Myin-Germeys I, Delespaul P, Viechtbauer W, van Zelst C, Bruggeman R, Reininghaus U, Morgan C, Murray RM, Di Forti M, McGuire P, Valmaggia LR, Kempton MJ, Gayer-Anderson C, Hubbard K, Beards S, Stilo SA, Onyejiaka A, Bourque F, Modinos G, Tognin S, Calem M, O'Donovan MC, Owen MJ, Holmans P, Williams N, Craddock N, Richards A, Humphreys I, Meyer-Lindenberg A, Leweke FM, Tost H, Akdeniz C, Rohleder C, Bumb JM, Schwarz E, Alptekin K, Üçok A, Saka MC, Atbaşoğlu EC, Gülöksüz S, Gumus-Akay G, Cihan B, Karadağ H, Soygür H, Cankurtaran EŞ, Ulusoy S, Akdede B, Binbay T, Ayer A, Noyan H, Karadayı G, Akturan E, Ulaş H, Arango C, Parellada M, Bernardo M, Sanjuán J, Bobes J, Arrojo M, Santos JL, Cuadrado P, Rodríguez Solano JJ, Carracedo A, García Bernardo E, Roldán L, López G, Cabrera B, Cruz S, Díaz Mesa EM, Pouso M, Jiménez E, Sánchez T, Rapado M, González E, Martínez C, Sánchez E, Olmeda MS, de Haan L, Velthorst E, van der Gaag M, Selten JP, van Dam D, van der Ven E, van der Meer F, Messchaert E, Kraan T, Burger N, Leboyer M, Szoke A, Schürhoff F, Llorca PM, J… See abstract for full author list ➔ European Network of National Networks studying Gene-Environment Interactions in Schizophrenia (EU-GEI), et al. Among authors: cabrera b. Schizophr Bull. 2014 Jul;40(4):729-36. doi: 10.1093/schbul/sbu069. Epub 2014 May 24. Schizophr Bull. 2014. PMID: 24860087 Free PMC article. Review.
Premorbid adjustment and clinical correlates of cognitive impairment in first-episode psychosis. The PEPsCog Study.
Cuesta MJ, Sánchez-Torres AM, Cabrera B, Bioque M, Merchán-Naranjo J, Corripio I, González-Pinto A, Lobo A, Bombín I, de la Serna E, Sanjuan J, Parellada M, Saiz-Ruiz J, Bernardo M; PEPs Group. Cuesta MJ, et al. Among authors: cabrera b. Schizophr Res. 2015 May;164(1-3):65-73. doi: 10.1016/j.schres.2015.02.022. Epub 2015 Mar 26. Schizophr Res. 2015. PMID: 25819935
A Pharmacovigilance Study in First Episode of Psychosis: Psychopharmacological Interventions and Safety Profiles in the PEPs Project.
Bioque M, Llerena A, Cabrera B, Mezquida G, Lobo A, González-Pinto A, Díaz-Caneja CM, Corripio I, Aguilar EJ, Bulbena A, Castro-Fornieles J, Vieta E, Lafuente A, Mas S, Parellada M, Saiz-Ruiz J, Cuesta MJ, Bernardo M; PEPs GROUP. Bioque M, et al. Among authors: cabrera b. Int J Neuropsychopharmacol. 2016 Mar 31;19(4):pyv121. doi: 10.1093/ijnp/pyv121. Print 2016 Apr. Int J Neuropsychopharmacol. 2016. PMID: 26506856 Free PMC article.
Dysregulated peripheral endocannabinoid system signaling is associated with cognitive deficits in first-episode psychosis.
Bioque M, Cabrera B, García-Bueno B, Mac-Dowell KS, Torrent C, Saiz PA, Parellada M, González-Pinto A, Lobo A, Leza JC, Bernardo M; FLAMM-PEPs Study - Centro de Investigación Biomédica en Red de Salud Mental. Bioque M, et al. Among authors: cabrera b. J Psychiatr Res. 2016 Apr;75:14-21. doi: 10.1016/j.jpsychires.2016.01.002. Epub 2016 Jan 6. J Psychiatr Res. 2016. PMID: 26783729
Pharmacogenetic study of antipsychotic induced acute extrapyramidal symptoms in a first episode psychosis cohort: role of dopamine, serotonin and glutamate candidate genes.
Mas S, Gassó P, Lafuente A, Bioque M, Lobo A, Gonzàlez-Pinto A, Olmeda MS, Corripio I, Llerena A, Cabrera B, Saiz-Ruiz J, Bernardo M; PEPs GROUP. Mas S, et al. Among authors: cabrera b. Pharmacogenomics J. 2016 Oct;16(5):439-45. doi: 10.1038/tpj.2016.44. Epub 2016 Jun 7. Pharmacogenomics J. 2016. PMID: 27272046
Opposite Cannabis-Cognition Associations in Psychotic Patients Depending on Family History.
González-Pinto A, González-Ortega I, Alberich S, Ruiz de Azúa S, Bernardo M, Bioque M, Cabrera B, Corripio I, Arango C, Lobo A, Sánchez-Torres AM, Cuesta MJ; PEPs Group. González-Pinto A, et al. Among authors: cabrera b. PLoS One. 2016 Aug 11;11(8):e0160949. doi: 10.1371/journal.pone.0160949. eCollection 2016. PLoS One. 2016. PMID: 27513670 Free PMC article.
221 results